BLUE NEVUS MELANOMA FOUNDATION

Close-up of a molecular biologist analyzing cell cultures under cool-toned laboratory light, shallow depth of field, 35mm
Close-up of a molecular biologist analyzing cell cultures under cool-toned laboratory light, shallow depth of field, 35mm
Join the Registry
Our Research
GNAQ/GNA11 Oncology

Targeting Blue Nevus Melanoma

We fund targeted molecular research and unite global clinical data to accelerate therapeutic breakthroughs for this exceptionally rare and aggressive cancer.

Active Progress

Our Research Footprint

2024

Patient-founded

GNAQ

Targeted mutation focus

UCSF

Scientific partnership

Dual Objectives

Advancing Rare Oncology

We operate at the intersection of patient advocacy and molecular science, driving progress through two critical clinical pillars.

Mutation Research

Global Registry

We fund drug repurposing studies and personalized cancer vaccines specifically targeting aggressive GNAQ and GNA11 genetic mutations.

We collect and secure clinical data from patients worldwide to build the robust datasets required to attract global pharmaceutical development.

Honest eye-level portrait of a clinical researcher and a patient advocate collaborating in a sunlit meeting room, soft natural window light
Honest eye-level portrait of a clinical researcher and a patient advocate collaborating in a sunlit meeting room, soft natural window light
Patient-Founded Origin

Urgency Born of Experience

Established in 2024 by a blue nevus melanoma patient, our foundation responds directly to the historical lack of clinical trials and targeted treatment options.

We bridge the gap between rigorous laboratory research and the human reality of diagnosis, ensuring no patient faces this rare disease without advocacy.

Register Now

Contribute Critical Patient Data

Your clinical information is the vital link researchers need to discover targeted therapies. Join our secure global registry today.